No Data
No Data
Jefferies Adjusts Cosmos Pharmaceutical's Price Target to 8,300 Yen From 7,900 Yen, Keeps at Buy
JP Morgan Asset Management increases its stake in COSMOS Pharmaceutical(3349.JP) to 6.26%
On Nov 6, JP Morgan Asset Management and related parties submitted the Change Report to Ministry of Finance. The report shows that JP Morgan Asset Management and related parties increased their
Cosmos Pharmaceuticals, Money Forward, etc. (additional) Rating
Upgrade - Bullish Code Stock Name Securities Company Original After Change -------------------------------------------------- <4902> Konica Minolta McCaulley "Neutral" "Outperform" Target Stock Price Change Code Stock Name Securities Company Original After Change -------------------------------------------------- <319
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of stocks for sale conversion market Code Company Name Closing Price SAR TSE Main Board <167A> Ryosan Hisho 2520 2641 <1833> Okumura Group 4310 4480 <1911> Sumitomo Lin 6143 6574 <1934> Yuat 1441 1572 <1942> Sekidenko 2104 2248 <1944> Kinden 3152 3320 <1961> Sangiko 2399 2508 <2335> Cubeshi
List of stocks with cloud breakout (weekly) [Ichimoku Kinko Hyo, List of stocks with cloud breakouts]
○ List of breakout stocks in the market Code Company Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board 1976 Meisei Kogyo 1257 1238.75 1129 2157 Koshidaka HD 1228 970 1135.5 2440 Gurunavi 3353 300.5 326.5 3076 Ai HD 2394 2375 2377.5 3183 Win P 1235 1228.25 1162 3
Driven by the weak yen, the consumer spending of tourists visiting Japan in the first 9 months has reached a new high.
①Driven by the weakness of the Japanese yen, Japan's tourism industry is extremely hot in 2024; ②Data shows that as of September, international tourists spent 5.86 trillion yen in Japan (equivalent to 39.27 billion US dollars); ③This exceeded the consumption record of 5.3 trillion yen set for the full year of 2023.
No Data
No Data